|
|||||
|
|
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab |
|
| Authors: | Hoshi Yuta Shirakura Satoshi Yamada Masato Sugiyama Tomonori Koide Nobuaki Tamii Satoru Kamata Kyohei Yokomura Masaru Osaki Sotaro Ohno Takafumi Yagihara Kazuhiro Hara Hiroki Beppu Takeshi |
| Affiliation: | 1.Department of Head and Neck Surgery, Saitama Prefectural Cancer Center, 780 Komuro, Ina-Machi, Kita-Adachi-Gun, Saitama, 362-0806, Japan ;2.Department of Head and Neck Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan ;3.Department of Otolaryngology, Head and Neck Surgery, Yamagata University Faculty of Medicine, 1-4-12 Kojirakawa-machi, Yamagata-shi, Yamagata, 990-8560, Japan ;4.Department of Oral Surgery, Saitama Prefectural Cancer Center, 780 Komuro, Ina-Machi, Kita-Adachi-Gun, Saitama, 362-0806, Japan ;5.Department of Gastroenterology, Saitama Prefectural Cancer Center, 780 Komuro, Ina-Machi, Kita-Adachi-Gun, Saitama, 362-0806, Japan ; |
| Abstract: | International Journal of Clinical Oncology - Nivolumab is approved for the treatment of recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the influence of the site of... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |